Bond Laboratories, Inc. - Now Publicly Traded
November 05 2007 - 1:48PM
PR Newswire (US)
SOLANA BEACH, Calif., Nov. 5 /PRNewswire-FirstCall/ -- Bond
Laboratories, Inc. (OTC:BNDB) (BULLETIN BOARD: BNDB) announced
today its shares have started to publicly trade on the OTC Exchange
in the United States under the symbol OTC.BB:BNDB. Eric Schick,
Bond's President, stated, "It just makes sense for us to pursue the
public market at this point in our growth. The equity markets are
just waking up to the potential for companies that are focused on
Nutraceutical Markets. As people live longer and healthcare costs
continue to rise at substantial multiples to the cost of living,
consumers recognize that prevention in the form of Nutraceutical
Dietary Supplements and Vitamins is critical. One just has to look
down the aisles of their local supermarket or drug store to see
that the amount of real estate being allocated to these categories
is continuously growing. We believe there is probably a 2-3 year
window of opportunity before everyone develops a strategy for
pursuing nutraceutical supplements, at which point it could be a
little late. Access to future mezzanine finance requirements as a
public entity, should be easier and receive higher valuations."
About Bond Laboratories: Bond Laboratories has brought together a
seasoned team of highly successful nutraceutical and pharmaceutical
sales and management executives. In the past, they have been
instrumental in bringing to market notable products in their many
forms such as multivitamins and herbal products, including
children's chewable vitamins, Warehouse Club multivitamins and
other specialty supplements. Bond is currently developing
proprietary products that address these three largest
mega-categories by focusing its product development, marketing, and
sales initiatives for unique marketing subgroups. Safe Harbor
Statements about the Company's future expectations and all other
statements in this press release other than historical facts, are
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Securities
Litigation Reform Act of 1995. The Company intends that such
forward-looking statements be subject to the safe harbors created
thereby. The above information contains information relating to the
Company that is based on the beliefs of the Company and/or its
management as well as assumptions made by and information currently
available to the Company or its management. When used in this
document, the words "anticipate," "estimate," "expect," "intend,"
"plans," "projects," and similar expressions, as they relate to the
Company or its management, are intended to identify forward-looking
statements. Such statements reflect the current view of the Company
regarding future events and are subject to certain risks,
uncertainties and assumptions, including the risks and
uncertainties noted. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
to be incorrect, actual results may vary materially from those
described herein as anticipated, believed, estimated, expected,
intended or projected. In each instance, forward-looking
information should be considered in light of the accompanying
meaningful cautionary statements herein. Factors that could cause
results to differ include, but are not limited to, successful
performance of internal plans, the impact of competitive services
and pricing and general economic risks and uncertainties.
DATASOURCE: Bond Laboratories, Inc. CONTACT: Scott Landow of Bond
Laboratories, Inc., +1-858-847-9000, fax, +1-858-847-9090,
Copyright